ClinConnect ClinConnect Logo
Search / Trial NCT06667258

Hearables: Ear-ECG and PPG for Detection of Cardiac Arrhythmias

Launched by IMPERIAL COLLEGE LONDON · Oct 29, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Hearables," is looking at a new way to detect abnormal heart rhythms, known as arrhythmias, by using devices that record signals from the ear. Researchers want to find out if these ear-based recordings, called Electrocardiogram (ECG) and Photoplethysmogram (PPG), can reliably identify arrhythmias in patients who already have this condition. They will compare the data from these ear devices to traditional methods of heart monitoring to see how well they work.

To participate in this study, you need to be between the ages of 65 and 74, be able to consent to participate, and already have a diagnosis of cardiac arrhythmia. If you have any unusual ear anatomy, you may not be eligible. If you decide to join the trial, you can expect to help researchers understand whether this new method of detection is as effective as current practices, which could lead to easier and more accessible heart health monitoring in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Able to give informed consent;
  • Healthy and diagnosed with cardiac arrhythmias.
  • Exclusion Criteria:
  • No abnormal ear anatomy

About Imperial College London

Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.

Locations

London, Non Us/Non Canadian, United Kingdom

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Nicholas S. Peters, MD

Principal Investigator

Imperial College London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported